The trial enrolled 80 women aged 45 and older diagnosed with breast cancer who were about to start neoadjuvant chemotherapy (NCT), a type of chemo given before surgery to shrink tumors. Participants were randomly assigned to receive either 2,000 IU of vitamin D daily or a placebo for six months, during their chemotherapy treatment.
